{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-005165","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2025-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.450403+00:00","generated_at":"2026-05-23T11:58:27.748193+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Vivos Therapeutics signs $9M deal to acquire Nevada sleep center operator SCN","bullets":["Total consideration up to $9M: $6M cash + $1.5M stock at closing + $1.5M stock earn-out.","SCN sees ~3,000 new patients/month; annual revenue in high seven figures; 7 locations in Nevada.","Close expected Q2/Q3 2025, subject to financing, audit, and customary conditions; no shareholder vote needed.","Employment agreement for Dr. Rachakonda includes $400K salary and board observation right; New Seneca Partners assisted."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-005165","json":"https://secwatch.observer/filing/0001641172-25-005165.json","markdown":"https://secwatch.observer/filing/0001641172-25-005165.md","text":"https://secwatch.observer/filing/0001641172-25-005165.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000164117225005165/0001641172-25-005165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000164117225005165/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T11:58:27.748193+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}